- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Report anticipates end to equipment purchase freezes
Most U.S. hospital radiology administrators expect restrictions against capital acquisitions to ease and plan to buy the diagnostic imaging equipment they most sorely need later this year, according to the latest report by healthcare market research firm IMV.
Most U.S. hospital radiology administrators expect restrictions against capital acquisitions to ease and plan to buy the diagnostic imaging equipment they most sorely need later this year, according to the latest report by healthcare market research firm IMV.
The Des Plaines, IL, firm surveyed 250 acute care hospitals. It found about 70% of radiology departments had partial or total capital equipment spending freezes in place because of the financial crisis. But it also found that radiology administrators in two of three hospitals plan to buy imaging equipment this year despite the recession. High-priority items include digital mammography, digital radiography, fluoroscopy, and multislice (64+) CT equipment. IMV found that many hospitals are scheduling the move toward PACS and that two of five current PACS users plan upgrades in the next two years.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
